Cargando…

Long non-coding RNA CCAT2 functions as an oncogene in hepatocellular carcinoma, regulating cellular proliferation, migration and apoptosis

An increasing number of studies have demonstrated that the dysregulation of long non-coding RNAs (lncRNAs) may serve an important role in tumor progression. Previous studies have reported that the lncRNA, colon cancer associated transcript 2 (CCAT2), was highly expressed in various tumors. However,...

Descripción completa

Detalles Bibliográficos
Autores principales:	ZHOU, NING, SI, ZHONGZHOU, LI, TING, CHEN, GUANGSHUN, ZHANG, ZHONGQIANG, QI, HAIZHI
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2016
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4906942/ https://www.ncbi.nlm.nih.gov/pubmed/27347113 http://dx.doi.org/10.3892/ol.2016.4580

Ejemplares similares

PIAS1 Alleviates Hepatic Ischemia-Reperfusion Injury in Mice through a Mechanism Involving NFATc1 SUMOylation
por: Luo, Jing, et al.
Publicado: (2022)

Knockdown of long non-coding RNA CCAT2 suppressed proliferation and migration of glioma cells
por: Guo, Hua, et al.
Publicado: (2016)

CCAT2 is an oncogenic long non-coding RNA in pancreatic ductal adenocarcinoma
por: Cai, Yi, et al.
Publicado: (2018)

CCAT 1- A Pivotal Oncogenic Long Non-Coding RNA in Colorectal Cancer
por: Liau, Xiew Leng, et al.
Publicado: (2023)

Foxp3-modified bone marrow mesenchymal stem cells promotes liver allograft tolerance through the generation of regulatory T cells in rats
por: Qi, Haizhi, et al.
Publicado: (2015)

Long Non-Coding RNA CCAT2 Activates RAB14 and Acts as an Oncogene in Colorectal Cancer
por: Wang, Dalu, et al.
Publicado: (2021)

Long Non-coding RNA CCAT1 Acts as an Oncogene and Promotes Sunitinib Resistance in Renal Cell Carcinoma
por: Shan, Liping, et al.
Publicado: (2020)

Roles of Long Non-Coding RNA CCAT2 in Cervical Cancer Cell Growth and Apoptosis
por: Wu, Le, et al.
Publicado: (2016)

Corrigendum: Long non-coding RNA CCAT1 acts as an oncogene and promotes sunitinib resistance in renal cell carcinoma
por: Shan, Liping, et al.
Publicado: (2023)

lncRNA CCAT1 promotes bladder cancer cell proliferation, migration and invasion
por: Zhang, Caixiang, et al.
Publicado: (2019)

Long non‐coding RNA CCAT1 sponges miR‐490 to enhance cell proliferation and migration of non‐small cell lung cancer
por: Wang, Jingluan, et al.
Publicado: (2020)

CCAT: Combinatorial Code Analysis Tool for transcriptional regulation
por: Jiang, Peng, et al.
Publicado: (2014)

Increased expression of long non-coding RNA CCAT2 predicts poorer prognosis in patients with hepatocellular carcinoma
por: Fu, Changbo, et al.
Publicado: (2019)

VIRMA-Dependent N6-Methyladenosine Modifications Regulate the Expression of Long Non-Coding RNAs CCAT1 and CCAT2 in Prostate Cancer
por: Barros-Silva, Daniela, et al.
Publicado: (2020)

Knockdown of Long Noncoding RNA CCAT2 Inhibits Cellular Proliferation, Invasion, and Epithelial–Mesenchymal Transition in Glioma Cells
por: Zeng, Jing, et al.
Publicado: (2017)

CCAT-1 promotes proliferation and inhibits apoptosis of cervical cancer cells via the Wnt signaling pathway
por: Zhang, Jun, et al.
Publicado: (2017)

Enhancer-derived long non-coding RNAs CCAT1 and CCAT2 at rs6983267 has limited predictability for early stage colorectal carcinoma metastasis
por: Thean, Lai Fun, et al.
Publicado: (2021)

Long non-coding RNAs CCAT1 and CCAT2 in colorectal liver metastases are tumor-suppressive via MYC interaction and might predict patient outcomes
por: Franz, Clemens, et al.
Publicado: (2023)

Oncogenic miR-425-5p is associated with cellular migration, proliferation and apoptosis in renal cell carcinoma
por: Quan, Jing, et al.
Publicado: (2018)

Hemodynamic alterations with large spontaneous splenorenal shunt ligation during adult deceased donor liver transplantation
por: Chen, Guangshun, et al.
Publicado: (2022)

H3K27 acetylation activated-long non-coding RNA CCAT1 affects cell proliferation and migration by regulating SPRY4 and HOXB13 expression in esophageal squamous cell carcinoma
por: Zhang, Erbao, et al.
Publicado: (2017)

LMNA functions as an oncogene in hepatocellular carcinoma by regulating the proliferation and migration ability
por: Liu, Heng, et al.
Publicado: (2020)

Long noncoding RNA CCAT1 acts as an oncogene and promotes chemoresistance in docetaxel-resistant lung adenocarcinoma cells
por: Chen, Jing, et al.
Publicado: (2016)

LncRNA CCAT2 promoted osteosarcoma cell proliferation and invasion
por: Yan, Lihua, et al.
Publicado: (2018)

Long non-coding RNA CCAT2 promotes prostate cancer cell proliferation and invasion by regulating the Wnt/β-catenin signaling pathway
por: He, Peng, et al.
Publicado: (2020)

Glioma cells enhance angiogenesis and inhibit endothelial cell apoptosis through the release of exosomes that contain long non-coding RNA CCAT2
por: Lang, Hai-Li, et al.
Publicado: (2017)

Long non-coding RNA CCAT1 promotes colorectal cancer cell migration, invasiveness and viability by upregulating VEGF via negative modulation of microRNA-218
por: Gu, Chao, et al.
Publicado: (2020)

The long non-coding RNA CCAT2 is up-regulated in ovarian cancer and associated with poor prognosis
por: Huang, Shuying, et al.
Publicado: (2016)

Upregulation of the c-MYC oncogene and adjacent long noncoding RNAs PVT1 and CCAT1 in esophageal squamous cell carcinoma
por: Roohinejad, Zahra, et al.
Publicado: (2023)

Long non-coding RNA CCAT1 as a diagnostic and prognostic molecular marker in various cancers: a meta-analysis
por: Zhang, Zhihui, et al.
Publicado: (2018)

Long noncoding RNA CCAT1 promotes hepatocellular carcinoma progression by functioning as let-7 sponge
por: Deng, Liang, et al.
Publicado: (2015)

CCAT2, a novel long non-coding RNA in breast cancer: expression study and clinical correlations
por: Redis, Roxana S, et al.
Publicado: (2013)

Prognostic value of long non-coding RNA CCAT1 expression in patients with cancer: A meta-analysis
por: Shi, Deyao, et al.
Publicado: (2017)

Vitamin D Suppresses Ovarian Cancer Growth and Invasion by Targeting Long Non-Coding RNA CCAT2
por: Wang, Liye, et al.
Publicado: (2020)

Clinicopathological and prognostic value of long non-coding RNA CCAT1 expression in patients with digestive system cancer
por: Yu, Yue, et al.
Publicado: (2023)

Association of lncRNA CCAT2 and CASC8 Gene Polymorphisms with Hepatocellular Carcinoma
por: Wu, Edie-Rosmin, et al.
Publicado: (2019)

LncRNA CCAT1 enhances chemoresistance in hepatocellular carcinoma by targeting QKI-5
por: Xia, Chongsheng, et al.
Publicado: (2022)

Downregulation of BRAF-activated non-coding RNA suppresses the proliferation, migration and invasion, and induces apoptosis of hepatocellular carcinoma cells
por: Li, Jing, et al.
Publicado: (2017)

LncRNA CCAT1 functions as apoptosis inhibitor in podocytes via autophagy inhibition
por: Su, Yanyan, et al.
Publicado: (2019)

Anti-oncogenic effects of SOX2 silencing on hepatocellular carcinoma achieved by upregulating miR-222-5p-dependent CYLD via the long noncoding RNA CCAT1
por: Pu, Jian, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4lb5p1a1hacnerv32d17tp0u7e